The new Congress and global health innovation
What are the implications for research to develop new health tools?
On the heels of the recent elections and a leadership shift in the House of Representatives, it is important to note that research for global health diseases has always garnered bipartisan support. As the new Congress prepares to start work in January, members of both parties should ensure that they sustain and elevate this long-standing prioritization of research and innovation for global health.
Read more 
Driving innovation for global health
In the current global economic crisis, how can the United States support and foster research for essential new global health tools? How can the country ensure that its investments in research for new health products—such as vaccines, drugs, and diagnostics—are cost-efficient and a wise use of limited resources? Incentives and innovative financing mechanisms have the potential to help answer these questions by spurring research and development for much-needed global health products while also ensuring that financial investments are cost-effective.
Read more
Agency spotlight: USAID
The US Agency for International Development (USAID) is the nation's lead foreign assistance agency, carrying out a broad humanitarian and development mission in more than 70 countries. The agency's leadership has recently prioritized science, technology, and innovation as core principles of how USAID carries out its international development work.
Read more about USAID and innovation in global development
Photos (second from top to bottom): Mike Wang, Satvir Malhotra
|
 |
|
|
November 2010
UPCOMING EVENTS
 November 23, 2010
Implications of Sub-Standard Drugs on People Living with HIV/AIDS and the Global Community
December 1, 2010
New Science, New Hope: Giving Women Power Over HIV/AIDS
NEW AND NOTEWORTHY
GHTC releases a new fact sheet on incentives and innovative financing for global health research
New report shows increase in research projects for diseases of the developing world
TB Alliance launches trial of new drug regimen
WHO report on neglected tropical diseases calls for increased research to develop new drugs, diagnostics, vaccines, and other health products
FDA meets with stakeholders to discuss next steps for experimental microbicide gel
GHTC calls for elevation of science and research in international development
MEMBER FOCUS
GHTC member the International AIDS Vaccine Initiative (IAVI) and partners recently announced the launch of a Phase I trial of two preventive AIDS vaccine candidates. The trial is the first to test these vaccine candidates in a regimen in which vaccines are given sequentially to boost immune system responses. The trial could eventually involve as many as six clinical research centers in the United States and Africa.
Read more |
|
Received this as a forward? Click here to sign up for future issues.
If you wish to unsubscribe, please click here to send us a message. We will remove your name from our mailing list as soon as possible.
The Global Health Technologies Coalition (GHTC) is a group of more than 30 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostic tests, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and improved regulatory systems. Learn more at www.ghtcoalition.org.
To see a list of GHTC members, click here.
We respect the privacy of our online relationships. our mailing lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law. |